Skip to main content

Intuitive Surgical cash flow statement

  • ISRG · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$443.59+0.84%Close 13 Nov 2026 · Market value $152.8B

In fiscal 2025 (the year to 31 Dec 2025), Intuitive Surgical generated $3.03B of operating cash flow and $2.49B of free cash flow, after $539.8M of capital expenditure.

From Intuitive Surgical's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Intuitive Surgical cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$144.5M$204.3M$232.6M$381.8M$495.1M$656.6M$671.0M$418.8M$588.8M$738.3M$670.9M$1.13B$1.38B$1.06B$1.70B$1.32B$1.80B$2.32B$2.86B$2.96B
Depreciation & amortization$13.03M$25.10M$34.60M$40.40M$46.50M$57.80M$67.30M$74.40M$85.50M$88.90M$95.00M$120.1M$200.0M$276.2M$310.2M$365.8M$454.8M$499.7M$677.1M$837.5M
Stock-based compensation$36.29M$76.60M$97.00M$117.6M$136.4M$153.3M$168.9M$168.9M$167.9M$177.6M$209.1M$261.2M$335.8M$395.4M$449.2M$513.2M$592.8M$676.8M$788.2M$835.3M
Operating cash flow$205.7M$278.2M$392.2M$545.8M$677.6M$814.2M$880.0M$665.1M$806.2M$1.09B$1.14B$1.17B$1.60B$1.48B$2.09B$1.49B$1.81B$2.42B$3.03B$4.09B
Operating cash flow margin34.2%31.8%37.3%38.6%38.6%37.4%38.9%31.2%33.8%40.2%36.5%31.4%35.7%34.1%36.6%24.0%25.5%28.9%30.1%35.3%
Capital expenditures$24.01M$106.0M$53.40M$96.00M$82.90M$114.2M$104.6M$105.6M$81.00M$53.90M$190.7M$187.4M$425.6M$341.5M$339.5M$532.4M$1.06B$1.11B$539.8M$491.5M
Acquisitions—————$27.60M$0.00$84.30M$0.00$0.00$0.00$87.90M$59.70M$37.70M$22.70M$12.80M$8.90M$1.00M$13.90M$550.5M
Free cash flow$181.7M$172.2M$338.8M$449.8M$594.7M$700.0M$775.4M$559.5M$725.2M$1.03B$953.2M$982.2M$1.17B$1.14B$1.75B$958.4M$749.6M$1.30B$2.49B$3.60B
Free cash flow margin30.2%19.7%32.2%31.8%33.8%32.1%34.2%26.2%30.4%38.2%30.4%26.4%26.2%26.2%30.6%15.4%10.5%15.6%24.7%31.1%
Free cash flow per share$0.52$0.48$0.96$1.24$1.64$1.89$2.15$1.65$2.13$2.92$2.73$2.76$3.27$3.17$4.78$2.65$2.10$3.60$6.87$10.07
Gross share repurchases$0.00$0.00$150.0M$198.6M$331.8M$238.3M$1.11B$1.00B$183.7M$42.50M$2.27B$0.00$269.5M$134.3M$0.00$2.61B$416.3M$0.00$2.30B$4.62B
Stock issuance proceeds—$44.70M$58.70M$141.1M$260.6M$263.3M$160.6M$283.6M$361.1M$580.9M$415.5M$237.0M$273.0M$309.0M$201.0M$146.0M$192.0M$315.0M$223.0M—
Net share repurchases$0.00−$44.70M$91.30M$57.50M$71.20M−$25.00M$948.6M$716.4M−$177.4M−$538.4M$1.86B−$237.0M−$3.50M−$174.7M−$201.0M$2.46B$224.3M−$315.0M$2.07B$4.62B
Free cash flow after SBC$145.4M$95.60M$241.8M$332.2M$458.3M$546.7M$606.5M$390.6M$557.3M$855.5M$744.1M$721.0M$836.8M$747.9M$1.30B$445.2M$156.8M$627.0M$1.70B$2.76B

Quarterly

Intuitive Surgical cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$606.2M$544.9M$526.9M$565.1M$685.7M$698.4M$658.4M$704.4M$794.8M$821.5M$818.1M$522.8M
Depreciation & amortization$123.2M$109.3M$111.8M$116.2M$124.7M$149.6M$164.4M$169.6M$193.5M$200.0M$231.1M$212.9M
Stock-based compensation$150.4M$153.3M$173.6M$172.9M$177.0M$185.2M$196.2M$203.5M$203.3M$209.5M$209.9M$212.6M
Operating cash flow$228.3M$265.4M$620.5M$706.5M$822.6M$581.6M$715.4M$841.0M$892.5M$911.9M$1.06B$1.22B
Operating cash flow margin11.8%14.0%30.9%34.7%34.1%25.8%29.3%33.6%31.1%32.9%36.7%40.2%
Capital expenditures$435.5M$241.9M$309.4M$247.9M$312.0M$116.6M$155.3M$105.4M$162.5M$103.3M$112.6M$113.1M
Acquisitions$1.80M——$0.00$1.00M$0.00$1.20M$0.00$12.70M$528.2M$0.00$9.60M
Free cash flow−$207.2M$23.50M$311.1M$458.6M$510.6M$465.0M$560.1M$735.6M$730.0M$808.6M$948.4M$1.11B
Free cash flow margin−10.7%1.2%15.5%22.5%21.2%20.6%23.0%29.4%25.5%29.2%32.8%36.4%
Free cash flow per share−$0.58$0.07$0.86$1.26$1.40$1.28$1.54$2.03$2.03$2.25$2.65$3.16
Dividends paid———$0.00———$0.00————
Gross share repurchases$66.30M$0.00$0.00$0.00$0.00$0.00$181.0M$1.91B$201.0M$1.12B$320.3M$2.98B
Net share repurchases$66.30M$0.00$0.00$0.00$0.00$0.00$181.0M$1.91B$201.0M$1.12B$320.3M$2.98B
Free cash flow after SBC−$357.6M−$129.8M$137.5M$285.7M$333.6M$279.8M$363.9M$532.1M$526.7M$599.1M$738.5M$898.4M

The main figures as JSON and plain text. See data and methodology.

ISRG in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.